Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.6 - $1.06 $1,013 - $1,790
-1,689 Reduced 1.88%
88,332 $53,000
Q3 2021

Nov 02, 2021

BUY
$1.33 - $1.77 $12,879 - $17,140
9,684 Added 12.05%
90,021 $119,000
Q2 2021

Aug 10, 2021

BUY
$1.41 - $1.94 $10,463 - $14,396
7,421 Added 10.18%
80,337 $115,000
Q1 2021

May 07, 2021

BUY
$1.61 - $2.77 $14,584 - $25,093
9,059 Added 14.19%
72,916 $131,000
Q4 2020

Feb 04, 2021

BUY
$1.55 - $2.24 $6,985 - $10,095
4,507 Added 7.59%
63,857 $111,000
Q3 2020

Oct 29, 2020

SELL
$1.91 - $3.08 $2,578 - $4,158
-1,350 Reduced 2.22%
59,350 $115,000
Q2 2020

Jul 27, 2020

BUY
$1.97 - $3.98 $4,925 - $9,950
2,500 Added 4.3%
60,700 $167,000
Q1 2020

May 08, 2020

BUY
$1.17 - $3.0 $24,160 - $61,950
20,650 Added 54.99%
58,200 $174,000
Q2 2019

Aug 15, 2019

BUY
$1.39 - $2.03 $29,815 - $43,543
21,450 Added 133.23%
37,550 $0
Q1 2019

May 08, 2019

SELL
$1.39 - $1.71 $2,703 - $3,325
-1,945 Reduced 10.78%
16,100 $0
Q4 2018

Feb 05, 2019

BUY
$1.41 - $2.16 $7,402 - $11,340
5,250 Added 41.03%
18,045 $25,000
Q1 2018

May 09, 2018

BUY
$1.34 - $2.03 $1,340 - $2,029
1,000 Added 8.48%
12,795 $0
Q4 2017

Feb 22, 2018

SELL
$1.65 - $2.45 $3,638 - $5,402
-2,205 Reduced 15.75%
11,795 $0
Q2 2017

Aug 08, 2017

BUY
N/A
14,000
14,000 $21,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.